Back to screener
Kabra Drugs Ltd
₹19.08
▼ 0.14 (-0.73%) today
Latest quote · Yahoo Finance
Market Cap
₹45 Cr
P/E (TTM)
6.0
P/B
1.5
Book Value
₹12.53
ROE
25.5%
Div Yield
—
D/E
0.02
EPS (TTM)
₹3.20
52W High
₹35.52
52W Low
₹15.50
Sales Growth
+546.40%
Profit Growth
—
Day High
₹19.83
Day Low
₹18.80
Volume
58,827
Fundamentals refreshed 18 hr ago · Statements just now · Source: Yahoo Finance
Quick Take
- • Trading at 6.0× trailing earnings
- • Strong ROE at 25.5%
- • Low leverage (D/E 0.02)
- • No dividend data
- • Operating margin 6.0% · Net margin 5.8%
- • Profit growth — YoY · Beta -0.13
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 46 | +31.43% | +557.14% |
| Operating Profit | 3 | +200.00% | — |
| Net Profit | 2 | +100.00% | — |
| EPS (₹) | 0.90 | +100.00% | +528.57% |
OPM 6.2% · Net margin 4.6% · prev quarter OPM 4.1%
Shareholding Pattern
Numbers in percentages · Source: Yahoo Finance
Promoters / Insiders25.80%
Public & Others74.20%
About the company
From latest AR & concall Reading the latest annual report and earnings call… (1–3 min on first visit)
Aanjaay Industries Limited engages in the manufacture and trade of pharmaceutical products. Its product portfolio includes cardiovascular, anti-infective, oncology, gastroenterologic, hormonal, and miscellaneous drugs; critical care injectibles, pre-filled syringes, and active pharmaceutical ingredients. The company was formerly known as Kabra Drugs Limited and changed its name to Aanjaay Industries Limited in July 2026. The company was incorporated in 1989 and is based in Chennai, India.
